Frequently asked questions by patients

 

Listed below are some of the most frequently asked questions by patients. If there is something you would like to know more about, please do contact a member of the BUS team, who will be happy to answer your questions.

 

Q: Do I have to take part in the study if my Doctor says I'm eligible?

A: No, it is entirely your choice. Your Doctor will explain all about the study to you, give you the opportunity to ask questions and, only if you are happy to consent, will then register you on to the study.

 

Q: Will I still receive the same treatment if I take part in the study?

A: Yes, your treatment on the NHS will remain the same, regardless of whether you are taking part in the study. The only difference will be the addition of the bladder ultrasound test, which is not currently used to diagnose overactive bladder.

 

Q: Can I withdraw from the study once I've enroled?

A: Yes, you are free to withdrawn from the study at any time, either by letting your Doctor know at the hospital or by contacting the BUS team.

 

Q: Can I get information about the study from an independent source?

A: Yes, your hospital's Patient Advice and Liaison Service will be able to provide you with information about the study. You can also get information from the BUS Study Team or from the Doctor at your hospital.

 

Q: Will the team contact me about the study in the future?

A: As part of the study we undertake a 6-month folllow-up of all the patients in the study. You will get a post test questionnaire through the post, along with another Quality of Life and Disease Severity questionnaire (like those you complete at the clinic when you have your tests), 6 months after your tests in clinic. This information helps us to understand how the bladder ultrasound could be implemented in the diagnosis of overactive bladder.

 

Q: Will I get to know the results of the Study?

A: We will be publishing the results of our study, once we have finished collecting and analysing all the data. These articles will be available to the general public.